Current Duke Appointments & Affiliations
Associate Professor of Medicine
·
2021 - Present
Medicine, Medical Oncology,
Medicine
Member of the Duke Cancer Institute
·
2021 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Scholarly Works
SPOP Mutations in Veterans With Prostate Cancer and Outcomes With Doublet and Triplet Therapy in De Novo Metastatic Hormone Sensitive Prostate Cancer.
Journal article Prostate · June 2026 BACKGROUND: Inactivating missense mutations in the tumor suppressor gene speckle-type pox virus and zinc finger protein (SPOP) occur in 5%-15% of men with prostate cancer (PC). SPOP mutations increase androgen receptor-mediated transcription and enhance se ... Full text Link to item CitePatterns of poly(ADP-ribose) polymerase inhibitor use and overall survival in United States veterans with prostate cancer.
Conference Journal of Clinical Oncology · June 1, 2026 e17049Background: PARP inhibitors (PARPi) are life-prolonging therapies for men with ... Full text CiteAnalysis of genomic and clinical predictors of overall survival and PSA response: Results from the PRECISION registry.
Conference Journal of Clinical Oncology · June 1, 2026 5051Background: Outcomes in advanced prostate cancer vary substantially according to ... Full text CiteRecent Grants
Prostate Cancer Research Program Clinical Consortium Award
ResearchCollaborator · Awarded by Department of Defense · 2026 - 2030DoD: PCRP Clinical Consortium: Duke University Clinical Research Site
ResearchCollaborating Investigator · Awarded by Department of Defense · 2007 - 2026PARPi Response Evaluation for Clinical Impact and Scientific Innovation in Oncology: The PRECISION Registry
ResearchCo Investigator · Awarded by Thomas Jefferson University · 2022 - 2022View All Grants
Education
Vanderbilt University ·
2005
M.D.